We are live on ! Find out more
IFAM

Institutional & Family Asset Management Portfolio holdings

AUM $654M
1-Year Est. Return 12.29%
This Fund
S&P 500
This Quarter Est. Return
+15.32%
1 Year Est. Return
+12.29%
3 Year Est. Return
+18.97%
5 Year Est. Return
+64.31%
10 Year Est. Return
–
AUM
$483M
AUM Growth
+$48.8M
Cap. Flow
+$192M
Cap. Flow %
39.85%
Top 10 Hldgs %
36.05%
Holding
946
New
103
Increased
193
Reduced
327
Closed
90

Top Buys

Rank Stock Value
1
CCOR icon
Core Alternative Capital
CCOR
+$6.89M
2
BIL icon
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
+$1.94M
3
VOO icon
Vanguard S&P 500 ETF
VOO
+$1.1M
4
VEA icon
Vanguard FTSE Developed Markets ETF
VEA
+$651K
5
SRVR icon
Pacer Data & Infrastructure Real Estate ETF
SRVR
+$317K

Top Sells

Rank Stock Value
1
CVX icon
Chevron
CVX
+$735K
2
OXY icon
Occidental Petroleum
OXY
+$643K
3
GPC icon
Genuine Parts
GPC
+$500K
4
EV
Eaton Vance Corp.
EV
+$452K
5
AFL icon
Aflac
AFL
+$440K

Sector Composition

Rank Sector Weight
1 Technology 9.12%
2 Industrials 6.99%
3 Healthcare 6.79%
4 Financials 6.37%
5 Consumer Staples 6.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JBTM
726
JBT Marel
JBTM
$6.15B
$2K ﹤0.01%
24
-7
-23% -$543
SUM
727
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
$2K ﹤0.01%
104
-31
-23% -$445
KRTX
728
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$2K ﹤0.01%
16
+2
+14% +$174
PRTK
729
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$2K ﹤0.01%
325
– –
BKI
730
DELISTED
Black Knight, Inc. Common Stock
BKI
$2K ﹤0.01%
27
– –
EVOP
731
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
$2K ﹤0.01%
80
-24
-23% -$477
LHCG
732
DELISTED
LHC Group LLC
LHCG
$2K ﹤0.01%
14
– –
TPTX
733
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$2K ﹤0.01%
+27
New +$1.56K
COHR
734
DELISTED
Coherent Inc
COHR
$2K ﹤0.01%
18
-6
-25% -$785
ARNA
735
DELISTED
Arena Pharmaceuticals Inc
ARNA
$2K ﹤0.01%
26
-8
-24% -$440
RDS.B
736
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$2K ﹤0.01%
64
– –
DRNA
737
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$2K ﹤0.01%
61
-18
-23% -$388
XLRN
738
DELISTED
Acceleron Pharma
XLRN
$2K ﹤0.01%
17
-5
-23% -$482
PFPT
739
DELISTED
Proofpoint, Inc.
PFPT
$2K ﹤0.01%
15
-5
-25% -$571
RP
740
DELISTED
RealPage, Inc.
RP
$2K ﹤0.01%
37
-11
-23% -$694
MNTA
741
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$2K ﹤0.01%
52
+4
+8% +$127
CCMP
742
DELISTED
CMC Materials, Inc. Common Stock
CCMP
$2K ﹤0.01%
17
-5
-23% -$647
BHVN
743
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$2K ﹤0.01%
22
-7
-24% -$373
AAT
744
American Assets Trust
AAT
$1.39B
$1K ﹤0.01%
+27
New +$739
ACB
745
Aurora Cannabis
ACB
$237M
$1K ﹤0.01%
9
– –
ACWX icon
746
iShares MSCI ACWI ex US ETF
ACWX
$12B
$1K ﹤0.01%
30
– –
AGIO icon
747
Agios Pharmaceuticals
AGIO
$2.04B
$1K ﹤0.01%
10
– –
AMN icon
748
AMN Healthcare
AMN
$1.26B
$1K ﹤0.01%
23
-7
-23% -$335
ARWR icon
749
Arrowhead Research
ARWR
$12.3B
$1K ﹤0.01%
32
+8
+33% +$282
BBD icon
750
Banco Bradesco
BBD
$34.9B
$1K ﹤0.01%
287
– –
28 29
30
31 32

Similar funds

SCM
Sahana Capital Management Greenwich, Connecticut $645M AUM 23.48% 1-Year Est. Return
PRC
Pearl River Capital Niles, Michigan $630M AUM 17.08% 1-Year Est. Return
GIM
Greylin Investment Management Orange, Virginia $598M AUM 18.59% 1-Year Est. Return
AT
Arden Trust Wilmington, Delaware $716M AUM 17.63% 1-Year Est. Return
MCM
McKinley Capital Management Anchorage, Alaska $571M AUM 36.44% 1-Year Est. Return
AC
Abbrea Capital Greenbrae, California $755M AUM 24.68% 1-Year Est. Return
RVPG
Relative Value Partners Group $772M AUM 15.6% 1-Year Est. Return
PWS
Private Wealth Strategies New Albany, Ohio $498M AUM 17.23% 1-Year Est. Return

Institutional & Family Asset Management's Q2 2020 Portfolio in Review

As of Q2 2020, Institutional & Family Asset Management held 946 positions worth $483M, up 11% from $434M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Institutional & Family Asset Management deployed $192M of net new capital in Q2 2020, opening 103 new positions and adding to 193 existing holdings. Its largest new stake was Vanguard FTSE Developed Markets ETF: 17,823 shares worth $691K.

By sector, the portfolio is most concentrated in Technology at 9.1% of assets, up from 7.9% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Chevron, an estimated $735K trimmed.

  • Institutional & Family Asset Management's largest Q2 2020 buy was Vanguard FTSE Developed Markets ETF: 17,823 shares worth $691K.
  • Institutional & Family Asset Management added most to Core Alternative Capital in Q2 2020, an estimated $6.89M increase.
  • Institutional & Family Asset Management's biggest Q2 2020 reduction was Chevron, cutting an estimated $735K.
  • Institutional & Family Asset Management fully exited ProShares UltraPro Short S&P 500 in Q2 2020, selling an estimated $96K.
  • Institutional & Family Asset Management's ten largest holdings make up 36% of its $483M portfolio in Q2 2020.
  • Institutional & Family Asset Management opened 103 new positions and closed 90 in Q2 2020.
  • Institutional & Family Asset Management's portfolio value rose 11% quarter-over-quarter to $483M.

Based on Institutional & Family Asset Management's 13F filing for Q2 2020, filed 14 Aug 2020.